HPV相关口咽鳞癌原发手术后未接受推荐辅助治疗者复发率增高但挽救治疗成功率高
未接受术后放疗者3年局部区域失败率为32%,接受者为4%(P < .001);但两组3年远处转移率(8% vs 4%,P = .56)和3年生存率(95% vs 98%,P = .34)无显著差异。结论:未接受指征性术后放疗者局部区域失败风险增加,但因挽救治疗成功率高,生存率相似。
要点
- HPV相关口咽鳞癌TORS术后未接受推荐PORT者3年局部区域失败率32%,显著高于接受者的4%。
- 未接受PORT未增加3年远处转移率(8% vs 4%)或降低3年生存率(95% vs 98%)。
- 单纯手术组复发多为局部或区域,且常可成功挽救。
核心结论
- HPV相关口咽鳞癌患者TORS术后未接受指征性PORT者局部区域失败风险增加,但因挽救治疗成功率高,生存率与接受PORT者相似。
主要发现
- 未接受PORT组3年局部区域失败率为32%,接受PORT组为4%(P < .001)。
- 未接受PORT组与接受PORT组3年远处转移率分别为8%和4%(P = .56)。
- 未接受PORT组与接受PORT组3年生存率分别为95%和98%(P = .34)。
- 单纯手术组复发部位包括局部和区域,且常可成功挽救。
关键数值与推荐
- PORT推荐基于TORS术后临床病理特征。
- 3年局部区域失败率:未接受PORT 32% vs 接受PORT 4%(P < .001)。
- 3年远处转移率:未接受PORT 8% vs 接受PORT 4%(P = .56)。
- 3年生存率:未接受PORT 95% vs 接受PORT 98%(P = .34)。
临床怎么用
- 对HPV相关口咽鳞癌TORS术后有PORT指征者,应充分告知未接受PORT的局部区域失败风险。
- 未接受PORT者需密切随访局部和区域复发,以便早期挽救治疗。
- 因远处转移和生存率相似,部分选择性患者或可在充分知情下避免PORT,但需进一步研究验证。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Some patients with human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) do not receive guideline-recommended postoperative radiation therapy (PORT) following primary transoral robotic surgery (TORS). METHODS: Three-hundred and sixty-four patients with treatment-naïve, HPV-associated OPSCC were recommended to receive PORT based on clinicopathological features following TORS. Patients were stratified based on if they received PORT. Oncologic outcomes were compared. RESULTS: The 3-year locoregional failure (LRF) was 32% in patients who did not receive PORT and 4% in patients who received PORT (P < .001). Despite increased LRF, avoiding PORT was not associated with increased 3-year distant metastasis rates (8% vs 4%, P = .56) or worse 3-year survival (95% vs 98%, P = .34). Recurrences in the surgery alone cohort varied between local and regional sites and were often successfully salvaged. CONCLUSIONS: Patients with HPV-associated OPSCC who do not receive indicated PORT have an increased risk of LRF but similar survival due to high salvage rates.
引用
- Carey RM, Shimunov D, Weinstein GS, et al. Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapy. Head Neck. 2020. PMID: 33325579. doi:10.1002/hed.26578
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。